Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

qually in Phase 3/4 development costs, and will share equally in sales and marketing expenses and profits of any product commercialized.

About Human Genome Sciences

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, anthrax disease, cancer and other immune-mediated diseases. The Company's primary focus is rapid progress toward the commercialization of its two key lead drugs, Albuferon(R) (albinterferon alfa- 2b) for hepatitis C and LymphoStat-B(R) (belimumab) for lupus. Phase 3 clinical trials of both drugs are ongoing.

ABthrax(TM) (raxibacumab) is in late-stage development for the treatment of anthrax disease, and the Company is on track to begin the delivery in 2008 of 20,000 doses of ABthrax to the Strategic National Stockpile under a contract entered into with the U.S. Government in June 2006. Other HGS drugs in clinical development include two TRAIL receptor antibodies for the treatment of cancers.

For more information about HGS, please visit the Company's Web site at http://www.hgsi.com. To view the AACR-NCI-EORTC poster presentation reporting results of the Phase 1b clinical trial of HGS-ETR2 in combination with chemotherapy, click here. To view the poster presentation reporting results of the preclinical studies of HGS-ETR1 and HGS-ETR2 with chemotherapy in cholangiocarcinoma, click here. Health professionals or patients interested in HGS-ETR1 or HGS-ETR2 clinical trials or other studies involving HGS products may inquire via the Contact Us section of the Company's web site, http://www.hgsi.com/products/request.html, or by calling us at (301) 610-5790, extension 3550.

Safe Harbor Statement

This announcement contains forward-looking stateme
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... LEUVEN, Belgium, December 16 , ... III Program With Microplasmin Recruits a Total ... ThromboGenics NV (Euronext ... discovery and development of innovative treatments for ... that it has completed,the enrolment of the ...
(Date:12/15/2009)... Dec. 15 Volcano Corporation (Nasdaq: ... therapy guidance tools - including Fractional Flow Reserve ... Optical Coherence Tomography (OCT) - designed to enhance ... vascular disease, announced today the placement of over ... family of consoles was first launched in April ...
(Date:12/15/2009)... CITY, Dec. 15 Sonic Innovations, Inc. ... services and solutions, donated $10,000 to its local ... Dec. 14, 2009. ,, Sonic Innovations President Paul ... Feeding America member, the Utah Food Bank, at ... employees also participated in an office food drive ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Wheat Consumption May Contribute to Diabetes 55456 1Hedgehog pathway may hold key to anti cancer therapy 55453 1Hedgehog pathway may hold key to anti cancer therapy 55453 2Briggs Program Improves Care in Nations Nursing Homes 55450 1Briggs Program Improves Care in Nations Nursing Homes 55450 2Briggs Program Improves Care in Nations Nursing Homes 55450 3
... July 14 SyntheMed, Inc. (OTC,Bulletin Board: ... development,and commercialization of anti-adhesion, drug delivery products ... the company,s,bioresorbable adhesion barrier film for the ... Health Canada approval for use in,pediatric patients ...
... BETHESDA, Md., July 14 Spherix Incorporated,(Nasdaq: ... trial of its potential,type 2 diabetes drug, Naturlose(R), ... with high prevalence of treatment-naive type II,diabetics are ... to,finish enrollment in the first quarter of 2009, ...
Other Medicine Technology:SyntheMed Receives Canadian Approval for REPEL-CV(R) 2Spherix Expands Phase 3 Naturlose Diabetes Trial Outside of the U.S. 2
(Date:12/16/2009)... new software program developed by CareRise will reduce the ... their staffing needs as it relates to the patient ... facilities to calculate their mandatory nurse-to-patient staffing needs, comply ... daily report as to how it affects their bottom ... management in the healthcare industry, has been allowed a ...
(Date:12/16/2009)... of a 1st century shrouded man found in a tomb ... revealed the earliest proven case of leprosy. Details of the ... ONE Journal. , The molecular investigation was undertaken by ... Sanford F. Kuvin Center for the Study of Infectious and ... Matheson and Ms. Kim Vernon of Lakehead University, Canada, Prof. ...
(Date:12/16/2009)... survey of Fortune 1000 employers strongly indicates that wellness programs ... benefits. , ... Minneapolis, MN (PRWEB) ... companies reveals that 78 percent of employers have improved employee ... program. In the survey, conducted by Hallmark Insights, ...
(Date:12/16/2009)... For ages, people from around the world ... Its soothing waters have a reputation that dates back ... with miracles. Now, with the introduction of two bath ... enjoy the legendary benefits of Dead Sea salt in ... contain all-natural Dead Sea salt and essential oils - ...
(Date:12/16/2009)... in the ,70s, study finds , , TUESDAY, Dec. 15 ... the United States than it was more than 30 ... Researchers compared National Health and Nutrition Examination Survey data ... 1972 and from 8,339 black and white participants from ... years old. , The prevalence of myopia increased from ...
Breaking Medicine News(10 mins):Health News:United States Patent Office Allows CareRise Patent on 24/7 Staff-Census Software 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 2Health News:SaltWorks Launches Two All-Natural Bath Salt Lines Featuring Therapeutic Salt from the Dead Sea 3
... Dental Management,Services, Inc. (Nasdaq: BDMS ), operators ... dividend. The Company,s board of directors,has declared a ... of common,stock. The dividend is payable July 11, ... Birner Dental Management Services, Inc. acquires, develops, and ...
... work together over next 60 days to try to ... Predictive medicine company,PreMD Inc. (TSX: PMD; Amex: PME) today ... U.S. Food and Drug Administration (FDA) in an,effort to ... for its non-invasive skin cholesterol test. Over the,next 60 ...
... they fret about kids, knowledge of safety, privacy, emergency practices, ... (HealthDay News) -- Many parents leave their tweens home alone ... not confident these 11- to 13-year-olds have the knowledge or ... The University of Michigan C.S. Mott Children,s Hospital National Poll ...
... Narconon,Trois-Rivieres, drug addiction is not a random coincidence. ... most instances by a problem, a particular,discomfort, an ... handle or fix. The individual will find it ... *(PHOTO Link: Send2Press.com/mediaboom/08-0613-Narconon_72dpi.jpg), (Photo Caption: Drug addiction ...
... Veterans Foundation (BAVF), at its June 14 picnic in ... "We,re honored to recognize Delegate Hixson for her ... to the entire State of,Maryland," said BAVF President John ... legislator and community activist are known,throughout Maryland.", The ...
... (PAH)chronically high blood pressure in the blood vessels of ... or HN) have a very poor chance of survival ... to new research from the University of Pennsylvania. ... advanced left heart failure but has never been demonstrated ...
Other Medicine News:Health News:PreMD Reports Further Positive Meetings with the FDA 2Health News:Parents Worry About Tweens Left Alone 2Health News:Drug Addiction Explained by Drug Addiction Center 2Health News:Blinded Vets Foundation to Honor Maryland State Delegate Sheila Hixson 2Health News:Serum sodium predicts mortality 10 times higher in PAH patients 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: